{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:55:59Z","timestamp":1789786559943,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/labinvest.2016.50","type":"journal-article","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T08:41:24Z","timestamp":1460968884000},"page":"731-740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Alpha-2, 3-sialyltransferases regulate the multidrug resistance of chronic myeloid leukemia through miR-4701-5p targeting ST3GAL1"],"prefix":"10.1016","volume":"96","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2016.50_bib1","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/leu.2010.159","article-title":"Insights into the stem cells of chronic myeloid leukemia","volume":"24","author":"Sloma","year":"2010","journal-title":"Leukemia"},{"key":"10.1038\/labinvest.2016.50_bib2","first-page":"95","article-title":"Cellular mechanisms of multidrug resistance of tumor cells","volume":"65","author":"Estey","year":"2000","journal-title":"Biochemistry (Mosc)"},{"key":"10.1038\/labinvest.2016.50_bib3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.biocel.2012.04.026","article-title":"Glycomic alterations are associated with multidrug resistance in human leukemia","volume":"44","author":"Zhang","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1038\/labinvest.2016.50_bib4","article-title":"Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells","volume":"10","author":"Nakana","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"10.1038\/labinvest.2016.50_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0300-9084(01)01301-3","article-title":"The human sialyltransferase family","volume":"83","author":"Harduin-Lepers","year":"2001","journal-title":"Biochimie"},{"key":"10.1038\/labinvest.2016.50_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-9-357","article-title":"ST3Gal I sialyltransferase relevance in bladder cancer tissues and cell lines","volume":"9","author":"Videira","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1038\/labinvest.2016.50_bib7","doi-asserted-by":"crossref","first-page":"26474","DOI":"10.1074\/jbc.M213223200","article-title":"Human alpha2, 3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase","volume":"278","author":"Saito","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.50_bib8","first-page":"4066","article-title":"Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer","volume":"58","author":"Recchi","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2016.50_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12032-010-9771-1","article-title":"Altered mRNA expressions of sialyltransferases in human gastric cancer tissues","volume":"29","author":"Jun","year":"2012","journal-title":"Med Oncol"},{"key":"10.1038\/labinvest.2016.50_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.leukres.2009.07.042","article-title":"Elevated mRNA level of hST6Gal I and hST3Gal V positively correlates with the high risk of pediatric acute leukemia","volume":"34","author":"Mondal","year":"2010","journal-title":"Leukemia Res"},{"key":"10.1038\/labinvest.2016.50_bib11","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1074\/jbc.274.17.11479","article-title":"Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids","volume":"274","author":"Okajima","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.50_bib12","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1056\/NEJMp058190","article-title":"MicroRNAs as oncogenes and tumor suppressors","volume":"353","author":"Chen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2016.50_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1038\/labinvest.2016.50_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/gb-2003-4-9-228","article-title":"Towards a complete description of the microRNA complement of animal genomes","volume":"4","author":"Brennecke","year":"2003","journal-title":"Genome Biol"},{"key":"10.1038\/labinvest.2016.50_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MOH.0b013e3283476012","article-title":"Role of microRNAs in lymphoid biology and disease","volume":"18","author":"Fabbri","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/labinvest.2016.50_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1535-7163.MCT-07-0573","article-title":"MicroRNAs modulate the chemosensitivity of tumor cells","volume":"7","author":"Blower","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/labinvest.2016.50_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/tpj.2008.14","article-title":"The impact of microRNAs and alternative splicing in pharmacogenomics","volume":"9","author":"Passetti","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"10.1038\/labinvest.2016.50_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3892\/ijo.2014.2390","article-title":"miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1","volume":"45","author":"Lu","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1038\/labinvest.2016.50_bib19","doi-asserted-by":"crossref","first-page":"e82062","DOI":"10.1371\/journal.pone.0082062","article-title":"Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/labinvest.2016.50_bib20","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1582-4934.2010.01213.x","article-title":"Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia","volume":"15","author":"Feng","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1038\/labinvest.2016.50_bib21","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.leukres.2009.10.002","article-title":"miR-138 might reverse multidrug resistance of leukemia cells","volume":"34","author":"Zhao","year":"2010","journal-title":"Leuk Res"},{"key":"10.1038\/labinvest.2016.50_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0925-4439(01)00044-8","article-title":"Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro","volume":"1536","author":"Zhu","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/labinvest.2016.50_bib23","first-page":"1365","article-title":"Differential expression of the \u03b12,3-sialic acid residues in breast cancer is associated with metastatic potential","volume":"25","author":"Cui","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1038\/labinvest.2016.50_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/gyno.2001.6358","article-title":"Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix","volume":"83","author":"Wang","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1038\/labinvest.2016.50_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2005.07.016","article-title":"Altered mRNA expression of sialyltransferases in ovarian cancers","volume":"99","author":"Wang","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1038\/labinvest.2016.50_bib26","first-page":"45","article-title":"Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia","volume":"50","author":"L\u00f3pez-Morales","year":"2009","journal-title":"Invest Clin"},{"key":"10.1038\/labinvest.2016.50_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs-microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/labinvest.2016.50_bib28","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.4161\/cc.6.12.4408","article-title":"CpG island hypermethylation of tumor suppressor microRNAs in human cancer","volume":"6","author":"Lujambio","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1038\/labinvest.2016.50_bib29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrg2634","article-title":"Causes and consequences of microRNA dysregulation in cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat Rev Genet"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201650","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722015331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722015331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:41:26Z","timestamp":1758397286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722015331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0023683722015331"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2016.50","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-2, 3-sialyltransferases regulate the multidrug resistance of chronic myeloid leukemia through miR-4701-5p targeting ST3GAL1","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2016.50","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}